Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Growth retardation, reduced invasiveness, and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumannii.

Pournaras S, Poulou A, Dafopoulou K, Chabane YN, Kristo I, Makris D, Hardouin J, Cosette P, Tsakris A, Dé E.

Antimicrob Agents Chemother. 2014;58(2):828-32. doi: 10.1128/AAC.01439-13. Epub 2013 Nov 18.

2.

Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections.

Lesho E, Yoon EJ, McGann P, Snesrud E, Kwak Y, Milillo M, Onmus-Leone F, Preston L, St Clair K, Nikolich M, Viscount H, Wortmann G, Zapor M, Grillot-Courvalin C, Courvalin P, Clifford R, Waterman PE.

J Infect Dis. 2013 Oct 1;208(7):1142-51. doi: 10.1093/infdis/jit293. Epub 2013 Jun 28.

PMID:
23812239
3.

A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.

Dahdouh E, Gómez-Gil R, Sanz S, González-Zorn B, Daoud Z, Mingorance J, Suárez M.

Int J Antimicrob Agents. 2017 Jun;49(6):727-733. doi: 10.1016/j.ijantimicag.2017.01.031. Epub 2017 Apr 21.

PMID:
28438568
4.

In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment.

Kim Y, Bae IK, Jeong SH, Yong D, Lee K.

Yonsei Med J. 2015 Jul;56(4):928-34. doi: 10.3349/ymj.2015.56.4.928. Erratum in: Yonsei Med J. 2017 Mar;58(2):474.

5.

Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness.

López-Rojas R, McConnell MJ, Jiménez-Mejías ME, Domínguez-Herrera J, Fernández-Cuenca F, Pachón J.

Antimicrob Agents Chemother. 2013 Sep;57(9):4587-9. doi: 10.1128/AAC.00543-13. Epub 2013 Jul 8.

6.

Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii.

Durante-Mangoni E, Del Franco M, Andini R, Bernardo M, Giannouli M, Zarrilli R.

Diagn Microbiol Infect Dis. 2015 Jul;82(3):222-6. doi: 10.1016/j.diagmicrobio.2015.03.013. Epub 2015 Mar 25.

PMID:
25858028
7.

Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system.

Adams MD, Nickel GC, Bajaksouzian S, Lavender H, Murthy AR, Jacobs MR, Bonomo RA.

Antimicrob Agents Chemother. 2009 Sep;53(9):3628-34. doi: 10.1128/AAC.00284-09. Epub 2009 Jun 15.

8.

Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.

Beceiro A, Llobet E, Aranda J, Bengoechea JA, Doumith M, Hornsey M, Dhanji H, Chart H, Bou G, Livermore DM, Woodford N.

Antimicrob Agents Chemother. 2011 Jul;55(7):3370-9. doi: 10.1128/AAC.00079-11. Epub 2011 May 16.

9.

Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy.

Giannouli M, Di Popolo A, Durante-Mangoni E, Bernardo M, Cuccurullo S, Amato G, Tripodi MF, Triassi M, Utili R, Zarrilli R.

Int J Antimicrob Agents. 2012 Jan;39(1):58-63. doi: 10.1016/j.ijantimicag.2011.09.016. Epub 2011 Nov 3.

PMID:
22055530
10.

In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates.

Peck KR, Kim MJ, Choi JY, Kim HS, Kang CI, Cho YK, Park DW, Lee HJ, Lee MS, Ko KS.

J Med Microbiol. 2012 Mar;61(Pt 3):353-60. doi: 10.1099/jmm.0.036939-0. Epub 2011 Oct 20.

PMID:
22016557
11.

In vivo emergence of colistin resistance in Acinetobacter baumannii clinical isolates of sequence type 357 during colistin treatment.

Kim Y, Bae IK, Lee H, Jeong SH, Yong D, Lee K.

Diagn Microbiol Infect Dis. 2014 Jul;79(3):362-6. doi: 10.1016/j.diagmicrobio.2014.03.027. Epub 2014 Apr 12.

PMID:
24809861
12.

Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.

García-Quintanilla M, Carretero-Ledesma M, Moreno-Martínez P, Martín-Peña R, Pachón J, McConnell MJ.

Int J Antimicrob Agents. 2015 Dec;46(6):696-702. doi: 10.1016/j.ijantimicag.2015.07.017. Epub 2015 Sep 7.

PMID:
26391380
13.

Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme.

Yau W, Owen RJ, Poudyal A, Bell JM, Turnidge JD, Yu HH, Nation RL, Li J.

J Infect. 2009 Feb;58(2):138-44. doi: 10.1016/j.jinf.2008.11.002. Epub 2008 Dec 6.

PMID:
19058855
14.

[Distribution of blaOXA genes in Acinetobacter baumannii strains: a multicenter study].

Ciftci IH, Aşık G, Karakeçe E, Oksüz L, Yağcı S, Sesli Çetin E, Ozdemir M, Atasoy AR, Koçoğlu E, Gül M, Kurtoğlu MG, Köksal Çakırlar F, Seyrek A, Berktaş M, Gültepe B, Ayyildiz A.

Mikrobiyol Bul. 2013 Oct;47(4):592-602. Turkish.

15.

Analyzing pmrA and pmrB genes in Acinetobacter baumannii resistant to colistin in Shahid Rajai Shiraz, Iran Hospital by PCR: First report in Iran.

Sepahvand S, Doudi M, Davarpanah MA, Bahador A, Ahmadi M.

Pak J Pharm Sci. 2016 Jul;29(4 Suppl):1401-6.

PMID:
27592491
16.

Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii.

López-Rojas R, Domínguez-Herrera J, McConnell MJ, Docobo-Peréz F, Smani Y, Fernández-Reyes M, Rivas L, Pachón J.

J Infect Dis. 2011 Feb 15;203(4):545-8. doi: 10.1093/infdis/jiq086. Epub 2011 Jan 7.

17.
18.

Impaired growth under iron-limiting conditions associated with the acquisition of colistin resistance in Acinetobacter baumannii.

López-Rojas R, García-Quintanilla M, Labrador-Herrera G, Pachón J, McConnell MJ.

Int J Antimicrob Agents. 2016 Jun;47(6):473-7. doi: 10.1016/j.ijantimicag.2016.03.010. Epub 2016 Apr 22.

PMID:
27179817
19.

In vitro responses of Acinetobacter baumannii to two- and three-drug combinations following exposure to colistin and doripenem.

Oleksiuk LM, Nguyen MH, Press EG, Updike CL, O'Hara JA, Doi Y, Clancy CJ, Shields RK.

Antimicrob Agents Chemother. 2014;58(2):1195-9. doi: 10.1128/AAC.01779-13. Epub 2013 Nov 18.

20.

In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.

Vila-Farres X, Garcia de la Maria C, López-Rojas R, Pachón J, Giralt E, Vila J.

Clin Microbiol Infect. 2012 Apr;18(4):383-7. doi: 10.1111/j.1469-0691.2011.03581.x. Epub 2011 Jun 14.

Supplemental Content

Support Center